New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
09:08 EDTZSPHZS Pharma receives notices of allowances from USPTO for ZS-9
ZS Pharma announced that it has received Notices of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Numbers 13/371,080 and 14/036,489 for ZS-9, the company’s product candidate in Phase 3 development for the treatment of hyperkalemia. The 13/371,080 Application describes compositions of matter that include ZS-9 and the 14/036,489 Application covers methods of treating hyperkalemia with compositions described in 13/371,080. The patents to be issued from these applications carry a patent term to at least 2032.
News For ZSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
08:27 EDTZSPHZS Pharma price target raised to $54 from $45 at BMO Capital
BMO Capital raised its price target on ZS Pharma as the firm thinks the market is appropriately upwardly adjusting its expectations for the potential of the company lead drug candidate, ZS-9, after positive data on the drug was released. The firm keeps an Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use